Cargando…
Combined treatment with artesunate and bromocriptine has synergistic anticancer effects in pituitary adenoma cell lines
Prolactinomas are the most prevalent functional pituitary adenomas. The preferred treatments for prolactinomas are dopamine agonists (DAs) such as bromocriptine (BRC), but DAs still have the challenges of tumor recurrence and drug resistance. This study demonstrates that the synergy of function and...
Autores principales: | Wang, Xin, Du, Qiu, Mao, Zhigang, Fan, Xiang, Hu, Bin, Wang, Zhen, Chen, Zhiyong, Jiang, Xiaobing, Wang, Zongming, Lei, Ni, Wang, Haijun, Zhu, Yonghong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5542234/ https://www.ncbi.nlm.nih.gov/pubmed/28501857 http://dx.doi.org/10.18632/oncotarget.17437 |
Ejemplares similares
-
Incidence rate and risk factors of early repolarization in patients with growth hormone-secreting pituitary adenoma: a cohort study
por: Chen, Zhiyong, et al.
Publicado: (2018) -
Prediction of the Recurrence of Non-Functioning Pituitary Adenomas Using Preoperative Supra-Intra Sellar Volume and Tumor-Carotid Distance
por: Chen, Wenli, et al.
Publicado: (2021) -
Prevalence and clinical characteristics of Crooke’s cell adenomas in 101 patients with T-PIT-positive pituitary adenomas: Case series and literature review
por: Zhu, Dimin, et al.
Publicado: (2022) -
Caveolin-1 sensitizes rat pituitary adenoma GH3 cells to bromocriptine induced apoptosis
por: Jiang, Yan-Nian, et al.
Publicado: (2007) -
Successful management of octreotide-insensitive thyrotropin-secreting pituitary adenoma with bromocriptine and surgery: A case report and literature review
por: Yang, Chengxian, et al.
Publicado: (2017)